News
New therapeutic strategies for breast cancer
The risk of developing breast cancer is largely determined by the ability of the cells to repair damage to their DNA and, at the same time, by the regulation of the “stem cells” that may eventually become tumors. However, it is unknown how these two fundamental processes co-regulate. In a recent study, IDIBELL – […]
Statement on Dr Manel Esteller leaving IDIBELL
The Bellvitge Biomedical Research Institute (IDIBELL) states that Dr Manel Esteller, ICREA researcher, professor at the University of Barcelona, and until now, coordinator of the Epigenetics and Cancer Biology Program (PEBC) at IDIBELL, has been appointed director of the Josep Carreras Leukaemia Research Institute, a position that implies the termination of his employment relationship with […]
400,000 dollars to fight prostate cancer
Dr. Álvaro Aytés (IDIBELL – ICO / ProCure) project receives an Idea Development Award from the American Department of Defense (DoD) within its Prostate Cancer Research Program.
Bioinformatics deciphers the metabolic characteristics of 25 types of cancer
Thanks to a bioinformatics analysis of 9,428 tumor samples, vulnerabilities potentially leading to new, more precise treatments are also identified
The 1st European Day GRIN2B brings together families suffering from this rare illness in Barcelona
Sant Joan de Déu Hospital hosts the event, through which parents will get to know the GRIN2B research team in Barcelona led by Dr. Xavier Altafaj, IDIBELL researcher
Dr. Manel Esteller, awarded by the ECO Foundation for Excellence and Quality of Oncology
Manel Esteller, director of the epigenetics and cancer biology program at IDIBELL, ICREA researcher and professor at the University of Barcelona, has received the Award of the ECO Foundation for Excellence and Quality in Oncology, awarded last Saturday 22nd at the Spanish Royal Academy of Medicine, in Madrid. The foundation has distinguished Dr. Esteller […]
ONCE and the Bellvitge Biomedical Research Institute (IDIBELL) renew their collaboration to study hereditary dystrophies of the retina
These dystrophies are disorders with great clinical and genetic heterogeneity for which there is no cure today; 15,000 people in Spain suffer from them
IDIBELL participates in the COST BESTPRAC meeting held in Belgrade, Serbia
The 10th BESTPRAC Working Group meeting was held from September 24-25 at the Faculty of Electrical Engineering, University of Belgrade, Serbia and gathered over 100 people from different European countries. IDIBELL attended the meeting as part of the action plan to boost its internationalization. COST BESTPRAC is one of the most relevant networks of research […]
IDIBELL researchers receive AECC grants on World Cancer Research Day
On the occasion of World Cancer Research Day (WCRD), which takes place every year on September 24th, the Spanish Association Against Cancer (AECC) awarded its 2018 AECC Cancer Research grants. The awards ceremony was chaired by Her Majesty the Queen, as Honorary President of the AECC and the AECC Scientific Foundation. This year, AECC has […]